Novavax Strengthens Vaccine Development Team with Two New Appointments Thursday May 11, 10:47 am ET * Dr. Jinyou Zhang Appointed as Senior Director of Bioprocess R & D * Dr. Niranjan Kumar Appointed as Senior Director of Commercial Manufacturing
MALVERN, Pa., May 11 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX - News) today announced the appointments of two senior biopharmaceutical scientists to augment the company's research and development and manufacturing capabilities. Dr. Jinyou Zhang, formerly senior investigator at Merck & Co., will serve as senior director of bioprocess R & D. Dr. Niranjan Kumar, who most recently was a deputy director at Sanofi Pasteur, has been named senior director of commercial manufacturing.
Related News Stories · Novavax Head of Pharmaceutical Development to Present on Micellar Nanoparticle Technology at Particles 2006 Meeting - PR Newswire (Wed May 10) · Novavax to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference - PR Newswire (Tue May 9) · Novavax Announces Release Date of First Quarter 2006 Financial Results and Investor Conference Call - PR Newswire (Fri May 5) · Novavax Earnings Call scheduled for Mon, May 15 - CCBN (Fri May 5) More...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.